South Africa vs Tunisia: Treatment success rate for patients treated for MDR-TB
South Africa
63.0%
in 2022
Tunisia
60.0%
in 2021
South Africa rank
118th
Tunisia rank
120th
Treatment success rate for patients treated for MDR-TB over time
- South Africa
- Tunisia
How they compare
South Africa currently reports 63.0% against 60.0% in Tunisia, a difference of 3.0%.
That makes South Africa's figure about 1.1 times Tunisia's.
The two have swapped places 1 time across 13 shared years of data; in 2008 it was Tunisia ahead.
South Africa ranks 118th and Tunisia ranks 120th of 163 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Africa | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.0% | 78.5% | 33.5% | Tunisia |
| 2010s | 52.9% | 73.7% | 20.8% | Tunisia |
| 2020s | 62.0% | 74.5% | 12.5% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, South Africa or Tunisia?
- South Africa, at 63.0% against 60.0% in Tunisia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between South Africa and Tunisia?
- 3.0%, with South Africa ahead.
- How many years of comparable data are there for South Africa and Tunisia?
- 13 years are reported by both, from 2008 to 2021.
- How do South Africa and Tunisia rank globally for treatment success rate for patients treated for mdr-tb?
- South Africa ranks 118th and Tunisia ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.